Clinical Trials Sponsored by Abramson Cancer Center at Penn Medicine

Total 476 results

Abramson Cancer Center at Penn Medicine

Not yet recruiting

FAPI-74 PET/CT in Adults With Fibrosis

Fibrosis (Morphologic Abnormality)

United States
Abramson Cancer Center at Penn Medicine

Recruiting

[18F]FES PET/.CT in Uterine Cancer

Uterine Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers

Gastrointestinal Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy (BreastVAX)

Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

Non-small Cell Lung Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab

Melanoma | Melanoma Stage III

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Cancer

Early Stage Non-Small Cell Lung Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

No Restrictions on Diagnosis

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

A Feasibility Study to Improve Colorectal Cancer Screening Among Racially Diverse Zip Codes in a Persistent Poverty County Using Navigation and Machine Learning Predictive Algorithms (PCSNaP)

Colorectal Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Project PLUS Lung Cancer Screening Promotion

Lung Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI)

Gastrointestinal Cancer

United States
Abramson Cancer Center at Penn Medicine

Completed

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Melanoma | Breast Cancer | Pancreatic Cancer | Metastatic | Non Small Cell Lung Cancer (NSCLC)

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects

Prostate Adenocarcinoma

United States
Abramson Cancer Center at Penn Medicine

Completed

Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer

Oligometastatic Non-small Cell Lung Cancer (NSCLC)

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

FDG PET/CT in Lung Cancer Staging

Non-Small Cell Lung Cancer (NSCLC)

United States
Abramson Cancer Center at Penn Medicine

Completed

Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Healthy Human Control Blood Collection for Validation of Biomarker Assay

Healthy

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

Esophageal Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Proton Radiation For Meningiomas and Hemangiopericytomas

Meningioma | Hemangiopericytoma

United States
Abramson Cancer Center at Penn Medicine

Completed

A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer

Advanced Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Completed

To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer

Colorectal Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab (CCTGuide Pilot)

Heart Failure | Breast Cancer | Cardiomyopathies | Risk Factor, Cardiovascular | Cardiotoxicity | Toxicity Due to Chemotherapy

United States
Abramson Cancer Center at Penn Medicine

Terminated

Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy

Pancreatic Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer

Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Personalized Radiation Therapy for GBM

Glioblastoma

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases

Neoplastic Disease

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Proton Radiation for Chordomas and Chondrosarcomas

Chordomas | Chondrosarcomas

United States
Abramson Cancer Center at Penn Medicine

Completed

Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation

Brain Lesions

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Limited-duration Teclistamab

Myeloma Multiple

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Whole Pelvis Proton Radiation for Gynecologic Cancer (GynWPProton)

Cervical Cancer | Uterine Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Collection of Circulating Biomarkers in Pancreatic Cancer

Pancreas Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

QOL and Sarcopenia in Patients With Ascites

Ascites Hepatic | Ascites, Malignant

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Shortened Course Adjuvant Radiotherapy Following TORS

Oropharyngeal Squamous Cell Carcinoma

United States
Abramson Cancer Center at Penn Medicine

Recruiting

FES BPET-DBT in Newly Diagnosed Breast Cancer

Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Improve Outcomes for Older Allogeneic Transplant Recipients

Allogeneic Transplantation

United States
Abramson Cancer Center at Penn Medicine

Recruiting

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

Head and Neck Cancer | Lung Cancer | Gastrointestinal Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Neoadjuvant PD-1 Blockade in Patients With Stage IIB/C Melanoma

Melanoma

United States
Abramson Cancer Center at Penn Medicine

Recruiting

PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer

Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Functional Outcome Measures for Head and Neck Patients

Otorhinolaryngology Subjects Undergoing Free Flap Surgery

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk

Pancreatic Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Ovarian Tissue Transplantation

Infertile Females or Females With Ovarian Insufficiency

United States
Abramson Cancer Center at Penn Medicine

Recruiting

The Radiation Oncology Registry and Biosample Repository

Patients With Pathologically Confirmed Neoplasia That Have Been | Selected for Definitive Photodynamic Therapy, Proton, or Photon Radiation Therapy

United States
Abramson Cancer Center at Penn Medicine

Completed

APBI Proton Feasibility and Phase II Study

Stage IA-IIA Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Terminated

Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary

Renal Cell Carcinoma | Renal Cell Carcinoma Stage IV

United States
Abramson Cancer Center at Penn Medicine

Terminated

A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Pancreatic Cancer

United States
Abramson Cancer Center at Penn Medicine

Enrolling by invitation

Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors (SENTINEL)

Hypertension | Atrial Fibrillation | Chronic Lymphocytic Leukemia | Cardiotoxicity

United States
Abramson Cancer Center at Penn Medicine

Completed

A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

Breast Cancer | Colorectal Cancer | Ovarian Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

AYA STEPS RCT: AYA Self-Management Via Texting, Education & Plans for Survivors

Adolescent and Young Adult (AYA) Cancer Survivors

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Evaluating Therapeutic Response to Novo-TTF

Glioblastoma Multiforme

United States

Clinical Trials Sponsored by Abramson Cancer Center at Penn Medicine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations